First discrete autoradiographic distribution of aminopeptidase N in various structures of rat brain and spinal cord using the selective iodinated inhibitor [125I]RB 129

Neuroscience

Volumn 105, Issue 2, 2001, Pages 479-488

  Noble, F ^a   Banisadr, G ^b   Jardinaud, F ^a   Popovici, T ^a   Lai Kuen, R ^c   Chen, H ^a   Bischoff, L ^a   Parsadaniantz, S Melik ^b   Fournie Zaluski, M C ^a   Roques, B P ^a  

^a Laboratoire de Pharmacochimie   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c NONE   (France)

Author keywords

Aminopeptidase N inhibitor; Enkephalins; Intestine; Neutral endopeptidase

Indexed keywords

2 BENZYL 3 [HYDROXY(1'AMINOETHYL)PHOSPHINYL]PROPANOYL 3 IODOTYROSINE; ENKEPHALIN; ENZYME INHIBITOR; IODINE 125; MEMBRANE METALLOENDOPEPTIDASE; MICROSOMAL AMINOPEPTIDASE; OPIATE PEPTIDE; OPIATE RECEPTOR; PROTEINASE; RB 129; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN BLOOD VESSEL; BRAIN REGION; CEREBELLUM CORTEX; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; INTESTINE BRUSH BORDER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD; TISSUE DISTRIBUTION;

EID: 0035958747     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(01)00185-3     Document Type: Article

References (65)

1. Regional distribution of soluble and membrane-bound aminopeptidase activities in rat brain
2. Preproenkephalin A gene expression in rat pineal
3. The role of corticotropin-releasing factor in depression and anxiety disorders
4. Localization of aminopeptidase N and dipeptidyl peptidase IV in pig striatum and in neuronal and glial cell cultures
5. Endogenous opioid pain control systems: Brainstem spinal pathways and endorphin circuitry
6. Peripheral and spinal mechanisms of nociception
7. Opioid peptides, receptors, and immune function
8. Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of Met-enkephalin-like material from the rat spinal cord
9. Peptidases and neuropeptide-inactivating mechanisms in the circulation and in the gastrointestinal tract
10. Aminophosphinic inhibitors as transition state analogues of enkephalin-degrading enzymes: A new class of central analgesics
11. Design of the first highly potent and selective aminopeptidase N (EC 3.4.11.2) inhibitor
12. Synthesis of 2(S)-benzyl-3-[hydroxy(1′(R)-amino ethyl)phosphinyl]propanoyl-L-3-[125I]-iodotyrosine: A radiolabelled inhibitor of aminopeptidase N
13. Hypothalamic-pituitary-adrenal axis hypersensitivity to naloxone in opioid dependence: A case of naloxone-induced withdrawal
14. The dual peptidase inhibitor RB 101 induces a long lasting increase in the extracellular level of Met-enkephalin in the nucleus accumbens of freely moving rats
15. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV
16. Pre- and post-natal ontogeny of neutral endopeptidase 24.11 ('enkephalinase') studied by in vitro autoradiography in the rat
17. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes
18. New dual inhibitors of neutral endopeptidase and angiotensin converting enzyme: Rational design, bioavailability and pharmacological responses on experimental hypertension
19. Membrane-bound cell surface peptidases in reproductive organs
20. Ectopeptidases of alveolar epithelium: Candidates for roles in alveolar regulatory mechanisms
21. Effects of acute and chronic administration of mu- and delta-opioid agonists on the hypothalamic-pituitary-adrenocortical (HPA) axis in the rat
22. Disappearance of energy-transfer as a tool for fluorimetric study of the degradation of enkephalins by aminopeptidase activity from mouse brain
23. Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis
24. Immunohistochemical localization of aminopeptidase M in rat brain and periphery: Relationship of enzyme localization and enkephalin metabolism
25. Structure and regional distribution of nociceptin/orphanin FQ precursor
26. Downregulation of neutral endopeptidase (EC 3.4.24.11) in the inflamed rat intestine
27. Angiotensin-converting enzyme (ACE) measurement in human serum using radioinhibitor ligand binding
28. Sound localization: Effects of unilateral lesions in central auditory system
29. Control of guinea-pig intestinal electrolyte secretion by a delta opioid receptor
30. Post mortem changes and regional distribution of substance P in the rat and mouse nervous system
31. Pathophysiology of HPA axis abnormalities in patients with major depression: An update
32. The 140-kDa protein of blood-brain barrier-associated pericytes is identical to aminopeptidase N
33. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N
34. Characterization of Glu350 as a critical residue involved in the N-terminal amine binding site of aminopeptidase N (EC 3.4.11.2): Insights into its mechanism of action
35. Anatomical distribution of opioid receptors in mammalians: An overview
36. Naloxone reversible antidiarrheal effects of enkephalinase inhibitors
37. The chemical neuroanatomy of the mammalian pineal gland: Neuropeptides
38. Nociceptin/orphanin FQ metabolism. Role of aminopeptidase and endopeptidase 24.15
39. Activation of mouse T lymphocytes by a monoclonal antibody to a developmentally regulated surface aminopeptidase (THAM)
40. Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor
41. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug RB 101 induces potent analgesic responses in mice and rats
42. Association of aminopeptidase N and endopeptidase 24.15 inhibitors potentiate behavioral effects mediated by nociceptin/orphanin FQ in mice
43. Binding properties of a highly potent and selective iodinated aminopeptidase N inhibitor appropriate for radioautography
44. Vascular, plasma membrane aminopeptidase M. Metabolism of vasoactive peptides
45. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis
46. Isolation of a novel endogenous opiate analgesic from human blood
47. Neutral endopeptidase 24.11. Structure, inhibition, and experimental and clinical pharmacology
48. Novel approaches to targeting neuropeptide systems
49. Degradation of dynorphin-related peptides by the puromycin-sensitive aminopeptidase and aminopeptidase M
50. Neutral endopeptidase 24.11 in rat peripheral tissues: Comparative localization by ex vivo and in vitro autoradiography
51. Nalmefene causes greater hypothalamic-pituitary adrenal axis activation than naloxone volunteers: Implication for the treatment of alcoholism
52. Evidence for opioid receptors on cells involved in host defense and the immune system
53. Purification of different amphiphilic forms of a microvillus aminopeptidase from pig small intestine using immunoadsorbent chromatography
54. Characterization of a soluble form of neutral endopeptidase-24.11 (EC 3.4.24.11) in human serum: Enhancement of its activity in serum of underground miners exposed to coal dust particles
55. Major localization of aminopeptidase M in rat brain microvessels
56. Angiotensin converting enzyme immunohistochemistry in rat brain and pituitary gland: Correlation of isoenzyme type with cellular localization
57. Immunochemical localization of aminopeptidase M in the alimentary tract of the guinea pig and rat
58. Similar involvement of several brain areas in the antinociception of endogenous and exogenous opioids
59. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain
60. Autoradiographic comparison of the distribution of the neutral endopeptidase 'enkephalinase' and of mu and delta opioid receptors in rat brain
61. Relationship between adrenocorticotropin, hypothalamic opioid tone, and plasma leptin
62. Human aminopeptidase N is a receptor for human coronavirus 229E
63. Properties required for reversible and irreversible radiolabelled probes for selective characterization of brain receptors and peptidases by autoradiography
64. Enkephalin-degrading enzymes and angiotensin-converting enzyme in human and rat meninges
65. A dynorphinergic pathway of Leu-enkephalin production in rat substantia nigra